Table 5.
Baseline | 3-months follow-up | 6-months follow-up | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Changes in structural complications between baseline and 3-months follow-up | Changes in structural complications between baseline and 6-months follow-up | |||||||||||||
(n = 103 eyes) | (n = 103 eyes) | (n = 103 eyes) | ||||||||||||
total | total | newly reported | no longer reported | total | newly reported | no longer reported | ||||||||
N | % | N | % | N | % | N | % | N | % | N | % | N | % | |
Any structural complication | 64 | 62.8 | 61 | 61.6 | 64 | 62.1 | ||||||||
Ocular hypotony (IOP ≤ 6 mmHg) during the last 3 months | 3 | 2.9 | 3 | 2.9 | 1 | 1.0 | 1 | 1.0 | 0 | 0.0 | 0 | 0.0 | 3 | 2.9 |
Ocular hypertension (IOP ≥ 21 mmHg) during the last 3 months | 6 | 5.8 | 6 | 5.8 | 2 | 1.9 | 2 | 1.9 | 4 | 3.9 | 1 | 1.0 | 3 | 2.9 |
Posterior synechiae formation | 50 | 48.5 | 51 | 49.5 | 1 | 1.0 | 0 | 0.0 | 53 | 51.5 | 3 | 2.9 | 0 | 0.0 |
Glaucoma | 4 | 3.9 | 3 | 2.9 | 0 | 0.0 | 1 | 1.0 | 5 | 4.9 | 1 | 1.0 | 0 | 0.0 |
Cataract | 18 | 17.5 | 17 | 16.5 | 2 | 1.9 | 3 | 2.9 | 24 | 23.3 | 6 | 5.8 | 0 | 0.0 |
Band keratopathy in the cornea | 25 | 24.3 | 25 | 24.3 | 2 | 1.9 | 2 | 1.9 | 26 | 22.9 | 2 | 1.9 | 0 | 0.0 |
Optic disc edema | 10 | 9.7 | 6 | 5.8 | 0 | 0.0 | 4 | 3.9 | 3 | 2.9 | 0 | 0.0 | 7 | 6.8 |
Macular edema | 10 | 9.7 | 5 | 4.9 | 2 | 1.9 | 7 | 6.8 | 3 | 2.9 | 1 | 1.0 | 8 | 7.8 |
Epiretinal membrane formation | 5 | 4.9 | 5 | 4.9 | 0 | 0.0 | 0 | 0.0 | 5 | 4.9 | 0 | 0.0 | 0 | 0.0 |
Vitreous haze | 14 | 13.6 | 13 | 12.6 | 4 | 3.9 | 5 | 4.9 | 13 | 12.6 | 5 | 4.9 | 6 | 5.8 |